|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Prometheus Biosciences, Inc. (RXDX) |
|
|
$199.92 0.00 (0.00%) as of 4:30 Thu 6/15
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
42,478,000 |
Market
Cap: |
8.49(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$198.65 - $199.92 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Prometheus Biosciences is a biotechnology company developing a precision medicine approach to the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, starting with inflammatory bowel disease. Co. utilizes its proprietary precision medicine platform, Prometheus360, which includes a gastrointestinal bioinformatics database and sample biobank, to identify therapeutic targets and develop therapeutic candidates to engage those targets. In parallel, Co. is developing companion diagnostic tests designed to identify patients more likely to respond to our therapeutic candidates.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
1,020,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$117,606,181 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
12 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Marshall Keith W |
Chief Financial Officer |
|
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,811 |
9,811 |
|
- |
|
Cedars Sinai Intellectual Property Co |
10% Owner |
|
2022-04-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(142,376) |
4,866,132 |
|
- |
|
Mckenna Mark C. |
Chairman, President & CEO |
|
2021-12-01 |
4 |
OE |
$2.90 |
$44,660 |
D/D |
15,400 |
15,400 |
|
- |
|
Cedars Sinai Intellectual Property Co |
10% Owner |
|
2021-06-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,008,508 |
|
55% |
|
Cormorant Private Healthcare Fund Iii Lp |
Former 10% Owner |
|
2021-03-16 |
4 |
B |
$19.00 |
$7,125,000 |
I/I |
375,000 |
2,223,022 |
0.01 |
-6% |
|
Cormorant Private Healthcare Fund Iii Lp |
Former 10% Owner |
|
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,848,022 |
1,848,022 |
|
- |
|
Cohen Steven A/sac Capital Mgmt Lp |
Former 10% Owner |
|
2021-03-16 |
4 |
B |
$19.00 |
$15,200,000 |
I/I |
800,000 |
2,648,024 |
0.01 |
-6% |
|
Cohen Steven A/sac Capital Mgmt Lp |
Former 10% Owner |
|
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,848,024 |
1,848,024 |
|
- |
|
Cedars Sinai Medical Center |
10% Owner |
|
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,416,008 |
5,008,508 |
|
- |
|
Yamada Tadataka |
and Chairman of the Board |
|
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
13,333 |
|
- |
|
Papa Joseph C |
Director |
|
2021-03-16 |
4 |
B |
$19.00 |
$285,000 |
D/D |
15,000 |
15,000 |
2.39 |
-6% |
|
Stenhouse Mark |
Chief Operating Officer |
|
2021-03-16 |
4 |
B |
$19.00 |
$266,000 |
D/D |
14,000 |
14,000 |
2.74 |
-6% |
|
Adams Helen C. |
Director |
|
2021-03-16 |
4 |
B |
$19.00 |
$9,500 |
D/D |
500 |
500 |
2.39 |
-6% |
|
Wong Roderick |
10% Owner |
|
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,464,031 |
3,264,031 |
|
- |
|
Wong Roderick |
10% Owner |
|
2021-03-16 |
4 |
B |
$19.00 |
$15,200,000 |
I/I |
800,000 |
800,000 |
1.5 |
-6% |
|
Edelman Joseph |
10% Owner |
|
2021-03-16 |
4 |
B |
$19.00 |
$16,150,000 |
I/I |
850,000 |
3,314,032 |
1.5 |
-6% |
|
Edelman Joseph |
10% Owner |
|
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,464,032 |
2,464,032 |
|
- |
|
Luo Allison |
Chief Medical OfficerOfficer |
|
2021-03-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
67,708 |
|
- |
|
Luo Allison |
Chief Medical OfficerOfficer |
|
2021-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
Cedars Sinai Medical Center |
10% Owner |
|
2021-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
592,500 |
|
- |
|
70 Records found
|
|
Page 3 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|